TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Arena Pharmaceuticals, Inc. Long Term Investor Investigation

  • If you are a current long term investor in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) securities, including those who purchased (also) prior to December 2008 and continue to presently hold those ARNA shares, you have certain options and you should contact the Shareholders Foundation.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

An Arena Pharmaceuticals investor has filed a lawsuit on behalf of all investors who purchased ARAN shares between Dec 8, 2008 and Sept. 16, 2010 against Arena Pharmaceuticals, Inc alleging violations of Federal Securities Laws in connection with the rejection of the lorcaserin New Drug Application by the US Food and Drug Administration. Meanwhile an investigation on behalf of current...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: